Ferhat Şirinyıldız
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ferhat Şirinyıldız has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Simge Ünay
Department of Biophysics, Faculty of Medicine, Uşak University, Uşak 64000, Türkiye
8 shared publications - Adem Keskin
Department of Medical Biochemistry, Faculty of Medicine, Aydin Adnan Menderes University, Aydin 09100, Turkey
6 shared publications - Rauf Onur Ek
ISTINYE UNIVERSITY, SCHOOL OF MEDICINE
6 shared publications - Gökhan Cesur
Adnan Menderes University, Turkey
5 shared publications - Nesibe Kahraman Çetin
Faculty of Medicine, Department of Medical Pathology, Aydın Adnan Menderes University, Efeler, Aydin, Turkey
3 shared publications - Nil Çulhacı
AYDIN ADNAN MENDERES ÜNİVERSİTESİ, TIP FAKÜLTESİ
3 shared publications
Latest Publications
- Open Access
- 7 November 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1179
Cellular Effects of a Topical Hemostatic Agent Used for Acute Bleeding Control: An in Vitro Study in MCF-7 and HEK-293 Cells
This exploratory in vitro study characterized 24 h responses to the topical hemostatic formulation Blood Stoper (TE’SIR) in MCF-7 and HEK-293 cells. Relative MTT reduction was assessed over 0.5–75% (v/v); qualitative scratch-gap observations and 24 h stained-cell aggregate counts were obtained in MCF-7 cells at 0.5%, 1%, and 7.5%, and supernatant malondialdehyde (MDA) and catalase readouts were obtained in both lines. In MCF-7 cells, the reported relative MTT signal declined from 72.61% at 0.5% to 15.23% at 7.5%; corresponding HEK-293 values were 114.30% and 35.44%. Images suggested impaired monolayer gap restoration, and fewer stained-cell aggregates were observed at higher exposures. Supernatant MDA and catalase readouts also varied across conditions. Inconsistencies in replication reporting, an unresolved MTT handling step, possible assay interference, and uncharacterized formulation pH, osmolality, and vehicle limit attribution of these patterns to biological effects. The results are descriptive and do not establish measured cell-survival fractions, oxidative injury mechanisms, tumor selectivity, or clinical biocompatibility. Independent validation in wound-relevant cells with formulation-matched controls is required.
- 7 November 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1179
Open AccessCellular Effects of a Topical Hemostatic Agent Used for Acute Bleeding Control: An in Vitro Study in MCF-7 and HEK-293 Cells
This exploratory in vitro study characterized 24 h responses to the topical hemostatic formulation Blood Stoper (TE’SIR) in MCF-7 and HEK-293 cells. Relative MTT reduction was assessed over 0.5–75% (v/v); qualitative scratch-gap observations and 24 h stained-cell aggregate counts were obtained in MCF-7 cells at 0.5%, 1%, and 7.5%, and supernatant malondialdehyde (MDA) and catalase readouts were obtained in both lines. In MCF-7 cells, the reported relative MTT signal declined from 72.61% at 0.5% to 15.23% at 7.5%; corresponding HEK-293 values were 114.30% and 35.44%. Images suggested impaired monolayer gap restoration, and fewer stained-cell aggregates were observed at higher exposures. Supernatant MDA and catalase readouts also varied across conditions. Inconsistencies in replication reporting, an unresolved MTT handling step, possible assay interference, and uncharacterized formulation pH, osmolality, and vehicle limit attribution of these patterns to biological effects. The results are descriptive and do not establish measured cell-survival fractions, oxidative injury mechanisms, tumor selectivity, or clinical biocompatibility. Independent validation in wound-relevant cells with formulation-matched controls is required.
- Open Access
- 1 October 2026
- Published by Experimental Biomedical Research in Experimental Biomedical Research
- Vol. 9 (4) , 336-347
Effects of pan-fried Ficus carica seed oil and sunflower oil on oxidative stress, inflammation, and tissue damage in rats
Aim: To compare the effects of long-term, regular pan-frying with sunflower oil and Ficus carica seed oil on liver and kidney damage in an experimental model. Method: For the experiment, 18 Wistar Albino rats were divided into 3 groups (n=6). The oils were pan fried for 15 minutes. The experimental animals in the Sunflower Oil group were given 3 ml/kg of pan-fried sunflower oil by orogastric gavage for 30 days, and the experimental animals in the Ficus carica Seed Oil group were given 3 ml/kg of pan-fried Ficus carica seed oil by orogastric gavage for 30 days. The rats in the control group were not given fried oil. At the end of the experiment, blood, liver and kidney tissues were taken from the sacrificed rats and biochemical and histopathological evaluations were performed. Results: The oxidative damage and proinflammatory parameters of sunflower oil were significantly higher than the control group. Liver and kidney damages were also higher than Ficus carica seed oil. In both pan fried oil groups, antioxidant levels decreased compared to the control group. In histopathological results, liver degeneration, portal inflammation, focal necrosis and apoptosis, peritoneal necrosis, sinusidal dilatation and centrilobular necrosis were found to be at lower levels in those applied with Ficus carica compared to the sunflower oil group. Conclusions: It was determined that Ficus carica seed oil caused less damage to the liver and kidney compared to pan-fried sunflower oil. It is recommended to prefer Ficus carica seed oil in pan fried foods.
- 1 October 2026
- Published by Experimental Biomedical Research in Experimental Biomedical Research
- Vol. 9 (4) , 336-347
Open AccessEffects of pan-fried Ficus carica seed oil and sunflower oil on oxidative stress, inflammation, and tissue damage in rats
Aim: To compare the effects of long-term, regular pan-frying with sunflower oil and Ficus carica seed oil on liver and kidney damage in an experimental model. Method: For the experiment, 18 Wistar Albino rats were divided into 3 groups (n=6). The oils were pan fried for 15 minutes. The experimental animals in the Sunflower Oil group were given 3 ml/kg of pan-fried sunflower oil by orogastric gavage for 30 days, and the experimental animals in the Ficus carica Seed Oil group were given 3 ml/kg of pan-fried Ficus carica seed oil by orogastric gavage for 30 days. The rats in the control group were not given fried oil. At the end of the experiment, blood, liver and kidney tissues were taken from the sacrificed rats and biochemical and histopathological evaluations were performed. Results: The oxidative damage and proinflammatory parameters of sunflower oil were significantly higher than the control group. Liver and kidney damages were also higher than Ficus carica seed oil. In both pan fried oil groups, antioxidant levels decreased compared to the control group. In histopathological results, liver degeneration, portal inflammation, focal necrosis and apoptosis, peritoneal necrosis, sinusidal dilatation and centrilobular necrosis were found to be at lower levels in those applied with Ficus carica compared to the sunflower oil group. Conclusions: It was determined that Ficus carica seed oil caused less damage to the liver and kidney compared to pan-fried sunflower oil. It is recommended to prefer Ficus carica seed oil in pan fried foods.
- Open Access
- 30 September 2026
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 9 (3) , 898-908
Comparison of Carboxyhemoglobin Levels, Pulmonary Functions, and Nicotine Dependence Among Smoking Healthcare Professionals in the Operating Theater
Objective:The aim of this study was to evaluate whether there are differences in carboxyhemoglobin (COHb) levels, pulmonary function, and nicotine dependence between smoking healthcare workers working in the operating theater and those working in internal medicine wards.Methods:This study was designed as a cross-sectional study. A total of 281 smoking healthcare workers, consisting of operating theater staff and internal medicine ward staff (141 operating theater, 140 ward), were included in the study. COHb levels of the participants were measured non-invasively using a pulse CO-oximeter. Pulmonary function tests (FEV₁, FVC, PEF, and FEV₁/FVC) were assessed using spirometry. Nicotine dependence was determined using the Fagerström Test for Nicotine Dependence. Appropriate parametric and non-parametric tests were used for intergroup comparisons, and relationships were analyzed using Spearman correlation analysis. Independent risk factors were evaluated using logistic regression analysis.Results:COHb levels were found to be significantly higher, while FVC and FEV₁/FVC ratios were significantly lower in operating theater staff (p
- 30 September 2026
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 9 (3) , 898-908
Open AccessComparison of Carboxyhemoglobin Levels, Pulmonary Functions, and Nicotine Dependence Among Smoking Healthcare Professionals in the Operating Theater
Objective:The aim of this study was to evaluate whether there are differences in carboxyhemoglobin (COHb) levels, pulmonary function, and nicotine dependence between smoking healthcare workers working in the operating theater and those working in internal medicine wards.Methods:This study was designed as a cross-sectional study. A total of 281 smoking healthcare workers, consisting of operating theater staff and internal medicine ward staff (141 operating theater, 140 ward), were included in the study. COHb levels of the participants were measured non-invasively using a pulse CO-oximeter. Pulmonary function tests (FEV₁, FVC, PEF, and FEV₁/FVC) were assessed using spirometry. Nicotine dependence was determined using the Fagerström Test for Nicotine Dependence. Appropriate parametric and non-parametric tests were used for intergroup comparisons, and relationships were analyzed using Spearman correlation analysis. Independent risk factors were evaluated using logistic regression analysis.Results:COHb levels were found to be significantly higher, while FVC and FEV₁/FVC ratios were significantly lower in operating theater staff (p
- 24 September 2026
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 27 (3) , 357-364
Determination of the Anti-Inflammatory and Antioxidant Effects of Arbutin in an Experimental Acute Pancreatitis Model
Objective: Purpose of our research is to assess the anti-inflammatory and antioxidant effects of arbutin in an experimental acute pancreatitis modelMaterials and Methods: Thirty-two female Wistar albino rats were utilized in this experiment and distributed equally among four groups: control, pancreatitis, low-dose arbutin treatment, and high-dose arbutin treatment. In pancreatic tissue, the levels of myeloperoxidase (MPO), trypsinogen activation peptide (TAP), catalase (CAT), interleukin-1 beta (IL-1β), malondialdehyde (MDA), superoxide dismutase (SOD), tumor necrosis factor-alpha (TNF-α), glutathione peroxidase (GPx), and interleukin-6 (IL-6) were measured. Additionally, serum levels of alpha-amylase and lipase were evaluated. Histopathological examination included assessment of vacuolization, inflammation, necrosis, and edema.Results: Compared to the pancreatitis group, both low- and high-dose arbutin treatment groups showed statistically significant decreases in alpha-amylase, MDA, and TAP levels, and GPx levels was significantly higher. Decrease in IL-6, MPO and IL-1 and increase in SOD levels were significant only in high dose arbutin group. . Histological examination showed a reduction in edema, inflammation, necrosis, and vacuolization however it was not statistically significant.Conclusion: Our study reveals that arbutin exhibits both antioxidant and anti-inflammatory effects in acute pancreatitis These results shows arbutin might potentially have a role in the prevention and treatment of both local and systemic complications of acute pancreatitis.
- 24 September 2026
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 27 (3) , 357-364
Determination of the Anti-Inflammatory and Antioxidant Effects of Arbutin in an Experimental Acute Pancreatitis Model
Objective: Purpose of our research is to assess the anti-inflammatory and antioxidant effects of arbutin in an experimental acute pancreatitis modelMaterials and Methods: Thirty-two female Wistar albino rats were utilized in this experiment and distributed equally among four groups: control, pancreatitis, low-dose arbutin treatment, and high-dose arbutin treatment. In pancreatic tissue, the levels of myeloperoxidase (MPO), trypsinogen activation peptide (TAP), catalase (CAT), interleukin-1 beta (IL-1β), malondialdehyde (MDA), superoxide dismutase (SOD), tumor necrosis factor-alpha (TNF-α), glutathione peroxidase (GPx), and interleukin-6 (IL-6) were measured. Additionally, serum levels of alpha-amylase and lipase were evaluated. Histopathological examination included assessment of vacuolization, inflammation, necrosis, and edema.Results: Compared to the pancreatitis group, both low- and high-dose arbutin treatment groups showed statistically significant decreases in alpha-amylase, MDA, and TAP levels, and GPx levels was significantly higher. Decrease in IL-6, MPO and IL-1 and increase in SOD levels were significant only in high dose arbutin group. . Histological examination showed a reduction in edema, inflammation, necrosis, and vacuolization however it was not statistically significant.Conclusion: Our study reveals that arbutin exhibits both antioxidant and anti-inflammatory effects in acute pancreatitis These results shows arbutin might potentially have a role in the prevention and treatment of both local and systemic complications of acute pancreatitis.
- 5 September 2026
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 15 (5)
Pharmacokinetic and toxicological properties of benzoic acid: integrated In silico characterization and In vitro validation with implications for dermatology
Benzoic acid (BA) is widely used in pharmaceutical, cosmetic, and dermatological formulations, yet its pharmacokinetic and toxicological profile has not been examined within a unified predictive and experimental framework. This study aimed to characterize BA using an integrated in silico and in vitro framework with dermatological implications, combining absorption, distribution, metabolism, excretion, and toxicity (ADMET) prediction, toxicity modeling, phenotype-driven molecular docking, and HEK293 cell assays. The BA structure was retrieved from PubChem and analyzed using pkCSM and ProTox-III for ADMET prediction. Molecular docking was performed with AutoDock Vina against eight phenotype-driven target proteins representing inflammation, oxidative stress, survival, and migration pathways. In vitro validation used HEK293 cells exposed to BA at 0, 15, 250, and 1,000 μM, with cell viability, wound-healing capacity, clonogenic capacity, lipid peroxidation (malondialdehyde), catalase activity, and total oxidant/antioxidant status assessed. BA showed favorable absorption and low predicted metabolic interaction liability, with platform-dependent discrepancies between pkCSM and ProTox-III regarding hepatotoxicity and blood–brain barrier penetration. Docking yielded moderate binding affinities (−5.175 to −6.388 kcal/mol), strongest against sphingosine-1-phosphate receptor 3, catalase, and cyclooxygenase-2. In HEK293 cells, BA produced dose-dependent reductions in viability (IC50 ≈ 242 μM), migration, and colony formation, alongside dose-dependent oxidative imbalance. Overall, BA displays a favorable pharmacokinetic profile but a mixed toxicological pattern. The predictive discrepancies and dose-dependent in vitro effects indicate caution in dermatological applications of BA and support further experimental studies on its cutaneous safety.
- 5 September 2026
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 15 (5)
Pharmacokinetic and toxicological properties of benzoic acid: integrated In silico characterization and In vitro validation with implications for dermatology
Benzoic acid (BA) is widely used in pharmaceutical, cosmetic, and dermatological formulations, yet its pharmacokinetic and toxicological profile has not been examined within a unified predictive and experimental framework. This study aimed to characterize BA using an integrated in silico and in vitro framework with dermatological implications, combining absorption, distribution, metabolism, excretion, and toxicity (ADMET) prediction, toxicity modeling, phenotype-driven molecular docking, and HEK293 cell assays. The BA structure was retrieved from PubChem and analyzed using pkCSM and ProTox-III for ADMET prediction. Molecular docking was performed with AutoDock Vina against eight phenotype-driven target proteins representing inflammation, oxidative stress, survival, and migration pathways. In vitro validation used HEK293 cells exposed to BA at 0, 15, 250, and 1,000 μM, with cell viability, wound-healing capacity, clonogenic capacity, lipid peroxidation (malondialdehyde), catalase activity, and total oxidant/antioxidant status assessed. BA showed favorable absorption and low predicted metabolic interaction liability, with platform-dependent discrepancies between pkCSM and ProTox-III regarding hepatotoxicity and blood–brain barrier penetration. Docking yielded moderate binding affinities (−5.175 to −6.388 kcal/mol), strongest against sphingosine-1-phosphate receptor 3, catalase, and cyclooxygenase-2. In HEK293 cells, BA produced dose-dependent reductions in viability (IC50 ≈ 242 μM), migration, and colony formation, alongside dose-dependent oxidative imbalance. Overall, BA displays a favorable pharmacokinetic profile but a mixed toxicological pattern. The predictive discrepancies and dose-dependent in vitro effects indicate caution in dermatological applications of BA and support further experimental studies on its cutaneous safety.
- 10 April 2026
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 57 (2)
Protective effects of Pelargonium sidoides against oxidative stress and inflammation in experimental mesenteric ischemia-reperfusion injury
Pelargonium sidoides is traditionally used in South African herbal medicine for the treatment of respiratory tract infections and has been commercialized in over 50 countries as EPs® 7630. While most clinical applications focus on respiratory conditions, the extract's potent antioxidant and anti-inflammatory properties suggest broader therapeutic potential. Mesenteric ischemia-reperfusion injury (IRI), characterized by oxidative stress and inflammation, is a serious complication during surgery and acute mesenteric ischemia. The aim of this study was to investigate the potential antioxidant and anti-inflammatory protective effects of Pelargonium sidoides root extract against oxidative stress and inflammation that may occur during IRI. Thirty male Wistar Albino rats were equally divided into three groups: control, mesenteric ischemia-reperfusion (MIR) and Pelargonium sidoides supplemented MIR (PS + MIR). The PS + MIR group received 30 mg/kg Pelargonium sidoides extract daily by intragastric gavage for 14 days before MIR induction. Small intestinal tissues were collected after the IRI procedure. Compared to controls, both MIR and PS + MIR groups showed increased levels of malondialdehyde, interleukin-1β, tumor necrosis factor-alpha, myeloperoxidase and superoxide dismutase inhibition rate, while catalase and glutathione peroxidase levels were decreased. However, these markers were significantly improved in the PS + MIR group compared to the MIR group. Histopathologically, severe damage such as villus deformation, epithelial loss, edema, hemorrhage and necrosis were observed in the MIR group, while only mild tissue irregularities were observed in the PS + MIR group. Pelargonium sidoides root extract has demonstrated a prophylactic protective effect against oxidative and inflammatory damage in experimental mesenteric ischemia-reperfusion injury.
- 10 April 2026
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 57 (2)
Protective effects of Pelargonium sidoides against oxidative stress and inflammation in experimental mesenteric ischemia-reperfusion injury
Pelargonium sidoides is traditionally used in South African herbal medicine for the treatment of respiratory tract infections and has been commercialized in over 50 countries as EPs® 7630. While most clinical applications focus on respiratory conditions, the extract's potent antioxidant and anti-inflammatory properties suggest broader therapeutic potential. Mesenteric ischemia-reperfusion injury (IRI), characterized by oxidative stress and inflammation, is a serious complication during surgery and acute mesenteric ischemia. The aim of this study was to investigate the potential antioxidant and anti-inflammatory protective effects of Pelargonium sidoides root extract against oxidative stress and inflammation that may occur during IRI. Thirty male Wistar Albino rats were equally divided into three groups: control, mesenteric ischemia-reperfusion (MIR) and Pelargonium sidoides supplemented MIR (PS + MIR). The PS + MIR group received 30 mg/kg Pelargonium sidoides extract daily by intragastric gavage for 14 days before MIR induction. Small intestinal tissues were collected after the IRI procedure. Compared to controls, both MIR and PS + MIR groups showed increased levels of malondialdehyde, interleukin-1β, tumor necrosis factor-alpha, myeloperoxidase and superoxide dismutase inhibition rate, while catalase and glutathione peroxidase levels were decreased. However, these markers were significantly improved in the PS + MIR group compared to the MIR group. Histopathologically, severe damage such as villus deformation, epithelial loss, edema, hemorrhage and necrosis were observed in the MIR group, while only mild tissue irregularities were observed in the PS + MIR group. Pelargonium sidoides root extract has demonstrated a prophylactic protective effect against oxidative and inflammatory damage in experimental mesenteric ischemia-reperfusion injury.
- 12 March 2026
- Published by Commagene Journal of Biology in Commagene Journal of Biology
- Vol. 10 (1)
Assessment of Locusta migratoria Protein Extract's Anticancer Potential on Breast Cancer Cells in vitro
Breast cancer remains a leading cause of cancer-related mortality worldwide, highlighting the urgent need for novel therapeutic strategies. Recently, insect-derived proteins have attracted interest due to their potential anticancer properties. This study investigates the effects of enzymatically extracted proteins from Locusta migratoria on the cell viability, scratch-wound, morphological changes, and colony-forming ability of MCF-7 breast cancer cells. Locusta migratoria enzymatic extract was applied to MCF-7 cells. Following treatment, the cytotoxic effect of the protein extract on the MCF-7 cells were evaluated using MTT assay, colony formation assay, scratch-wound assay, and Toluidine Blue staining. Cell viability decreased significantly in a dose-dependent manner following treatment with the protein extracts (p < 0.0001). Colony formation was also reduced as the protein concentration increased. Also, in MCF-7 cells, the control group showed approximately 90% wound closure in contrast to the 20.17- 97.25% opening observed in cells treated with protein extract. Morphological changes such as loss of appendages, nuclear condensation, chromatin compaction, and an increase in apoptotic bodies, indicating enhanced apoptosis, were observed in the cells. To the best of our knowledge, this is the first study examining the biological effects on MCF-7 cells of protein extracts from Locusta migratoria generated enzymatically. In conclusion, enzymatically extracted proteins from Locusta migratoria exhibit significant cytotoxic and anti-proliferative effects on MCF-7 cells in vitro. These findings suggest that such protein extracts may represent a promising source of bioactive compounds for breast cancer treatment. However, further studies are required to elucidate the underlying molecular mechanisms and to evaluate their selectivity and safety profiles.
- 12 March 2026
- Published by Commagene Journal of Biology in Commagene Journal of Biology
- Vol. 10 (1)
Assessment of Locusta migratoria Protein Extract's Anticancer Potential on Breast Cancer Cells in vitro
Breast cancer remains a leading cause of cancer-related mortality worldwide, highlighting the urgent need for novel therapeutic strategies. Recently, insect-derived proteins have attracted interest due to their potential anticancer properties. This study investigates the effects of enzymatically extracted proteins from Locusta migratoria on the cell viability, scratch-wound, morphological changes, and colony-forming ability of MCF-7 breast cancer cells. Locusta migratoria enzymatic extract was applied to MCF-7 cells. Following treatment, the cytotoxic effect of the protein extract on the MCF-7 cells were evaluated using MTT assay, colony formation assay, scratch-wound assay, and Toluidine Blue staining. Cell viability decreased significantly in a dose-dependent manner following treatment with the protein extracts (p < 0.0001). Colony formation was also reduced as the protein concentration increased. Also, in MCF-7 cells, the control group showed approximately 90% wound closure in contrast to the 20.17- 97.25% opening observed in cells treated with protein extract. Morphological changes such as loss of appendages, nuclear condensation, chromatin compaction, and an increase in apoptotic bodies, indicating enhanced apoptosis, were observed in the cells. To the best of our knowledge, this is the first study examining the biological effects on MCF-7 cells of protein extracts from Locusta migratoria generated enzymatically. In conclusion, enzymatically extracted proteins from Locusta migratoria exhibit significant cytotoxic and anti-proliferative effects on MCF-7 cells in vitro. These findings suggest that such protein extracts may represent a promising source of bioactive compounds for breast cancer treatment. However, further studies are required to elucidate the underlying molecular mechanisms and to evaluate their selectivity and safety profiles.
- Open Access
Protective Effects of Betanin in Acute and Subacute Periods in Experimental Colitis Induced by Trinitrobenzene Sulfonic Acid
Background/Objectives: This study aims to investigate the effects of betanin, which possesses antioxidant and anti-inflammatory properties, against colitis, a disease in which inflammation and oxidative stress play a role in its pathophysiology, during the acute and subacute period. Methods: Thirty-two rats were included in the study and divided into four groups: control, colitis, 3-day betanin supplementation + colitis (bet3+colitis), and 15-day betanin supplementation + colitis (bet15+colitis). Experimental colitis was induced with trinitrobenzene sulfonic acid. Results: In the colitis group, malondialdehyde, myeloperoxidase, superoxide dismutase (SOD) inhibition rate, tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-6, mucosal damage, and cell infiltration scores were higher than in the control group, while catalase and glutathione peroxidase (GPx) levels were lower. In the betanin supplementation groups, malondialdehyde, myeloperoxidase, TNF-α, IL-1β, mucosal damage, and cell infiltration scores were lower than in the colitis group, while GPx levels were higher. In addition, the SOD inhibition rate and interleukin-6 levels were lower in the bet15+colitis group than in the colitis group. TNF-α, IL-1β, interleukin-6, and GPx levels in the betanin groups were similar to the control group. Conclusions: Betanin supplementation demonstrated a significant anti-inflammatory effect by reducing inflammatory parameters and histopathological scores in both periods. Additionally, it exhibited a glutathione-related antioxidant effect by increasing GPx levels in both periods. However, although SOD inhibition rates decreased in the subacute period, no significant change in catalase levels was observed in either period. This indicates that it did not provide complete protection in terms of antioxidant effects in either period.
Open AccessProtective Effects of Betanin in Acute and Subacute Periods in Experimental Colitis Induced by Trinitrobenzene Sulfonic Acid
Background/Objectives: This study aims to investigate the effects of betanin, which possesses antioxidant and anti-inflammatory properties, against colitis, a disease in which inflammation and oxidative stress play a role in its pathophysiology, during the acute and subacute period. Methods: Thirty-two rats were included in the study and divided into four groups: control, colitis, 3-day betanin supplementation + colitis (bet3+colitis), and 15-day betanin supplementation + colitis (bet15+colitis). Experimental colitis was induced with trinitrobenzene sulfonic acid. Results: In the colitis group, malondialdehyde, myeloperoxidase, superoxide dismutase (SOD) inhibition rate, tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-6, mucosal damage, and cell infiltration scores were higher than in the control group, while catalase and glutathione peroxidase (GPx) levels were lower. In the betanin supplementation groups, malondialdehyde, myeloperoxidase, TNF-α, IL-1β, mucosal damage, and cell infiltration scores were lower than in the colitis group, while GPx levels were higher. In addition, the SOD inhibition rate and interleukin-6 levels were lower in the bet15+colitis group than in the colitis group. TNF-α, IL-1β, interleukin-6, and GPx levels in the betanin groups were similar to the control group. Conclusions: Betanin supplementation demonstrated a significant anti-inflammatory effect by reducing inflammatory parameters and histopathological scores in both periods. Additionally, it exhibited a glutathione-related antioxidant effect by increasing GPx levels in both periods. However, although SOD inhibition rates decreased in the subacute period, no significant change in catalase levels was observed in either period. This indicates that it did not provide complete protection in terms of antioxidant effects in either period.
- Open Access
- 25 December 2025
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 27 (3) , 339-345
The Prophylactic and Therapeutic Effects of Ficus carica Seed Oil on TNBS-Induced Experimental Model of Ulcerative Colitis
Aim: Ficus carica (fig) fruit is known for its rich bioactive content and medicinal properties. Fig seed oil, in particular, contains high levels of antioxidants and tocopherols. This study aimed to evaluate the potential preventive and therapeutic effects of cold-pressed fig seed oil on 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced experimental colitis in rats. Material and Methods: Sixty Wistar albino rats were divided into six groups: Sham, TNBS, and Ficus carica seed oil administration for 3-day 3 mL/kg (SFC3), 3-day 6 mL/kg (SFC6), 15-day 3 mL/kg (LFC3), and 15-day 6 mL/kg (LFC6). Colitis was induced using TNBS dissolved in 37% ethanol. Fig seed oil was administered at 3 mL/kg and 6 mL/kg doses, once daily for 12 days prior to induction and 3 days post-induction for long-term (15-day) groups, while for short-term (3-day) groups, it was administered once daily for 3 days after induction. Results: Histological analysis revealed significantly lower tissue damage in fig seed oil-treated groups compared to the TNBS group. Long-term treatment groups showed better histopathological recovery than short-term treatment groups. Biochemical markers of inflammation and oxidative stress, including myeloperoxidase (MPO), malondialdehyde (MDA), interleukin-1 (IL-1), and tumor necrosis factor-alpha (TNF-α), were significantly reduced in treatment groups. Conversely, antioxidant enzyme levels, superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), were significantly higher. These biochemical findings were consistent with histological improvements. Conclusion: Cold-pressed fig seed oil may exert therapeutic effects against colitis through its anti-inflammatory and antioxidant properties. It shows promise as a supplementary treatment option for inflammatory bowel disease.
- 25 December 2025
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 27 (3) , 339-345
Open AccessThe Prophylactic and Therapeutic Effects of Ficus carica Seed Oil on TNBS-Induced Experimental Model of Ulcerative Colitis
Aim: Ficus carica (fig) fruit is known for its rich bioactive content and medicinal properties. Fig seed oil, in particular, contains high levels of antioxidants and tocopherols. This study aimed to evaluate the potential preventive and therapeutic effects of cold-pressed fig seed oil on 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced experimental colitis in rats. Material and Methods: Sixty Wistar albino rats were divided into six groups: Sham, TNBS, and Ficus carica seed oil administration for 3-day 3 mL/kg (SFC3), 3-day 6 mL/kg (SFC6), 15-day 3 mL/kg (LFC3), and 15-day 6 mL/kg (LFC6). Colitis was induced using TNBS dissolved in 37% ethanol. Fig seed oil was administered at 3 mL/kg and 6 mL/kg doses, once daily for 12 days prior to induction and 3 days post-induction for long-term (15-day) groups, while for short-term (3-day) groups, it was administered once daily for 3 days after induction. Results: Histological analysis revealed significantly lower tissue damage in fig seed oil-treated groups compared to the TNBS group. Long-term treatment groups showed better histopathological recovery than short-term treatment groups. Biochemical markers of inflammation and oxidative stress, including myeloperoxidase (MPO), malondialdehyde (MDA), interleukin-1 (IL-1), and tumor necrosis factor-alpha (TNF-α), were significantly reduced in treatment groups. Conversely, antioxidant enzyme levels, superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), were significantly higher. These biochemical findings were consistent with histological improvements. Conclusion: Cold-pressed fig seed oil may exert therapeutic effects against colitis through its anti-inflammatory and antioxidant properties. It shows promise as a supplementary treatment option for inflammatory bowel disease.
- Open Access
- 22 December 2025
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 50 (4) , 1114-1122
Benzoic acid exerts antiproliferative, anti-migratory, and anti-clonogenic effects on MCF-7 breast cancer cells
Purpose: This study aims to investigate and emphasize the anticancer potential of benzoic acid in breast cancer cells. Materials and Methods: MCF-7 breast cancer cells were treated with benzoic acid at concentrations ranging from 0 to 1000 µM and incubated for 24 hours. Following treatment, both the effective and cytotoxic doses of benzoic acid were determined. Using these defined concentrations, comprehensive analyses were conducted to evaluate cell viability, cell migration (wound scratch assay), and clonogenic potential (colony formation assay), in order to elucidate the anticancer effects of benzoic acid. Results: Benzoic acid BA inhibited MCF-7 cell viability, migration, and colony formation in a dose-dependent manner. Cell viability was significantly reduced at concentrations ≥31.25 µM, with an IC₅₀ of ~166 µM, and dropped below 20% at 1000 µM. BA suppressed cell migration starting at 15 µM, reaching maximal inhibition at 1000 µM. Colony formation was also markedly impaired, with higher concentrations (250–1000 µM) nearly abolishing clonogenic potential. Conclusion: Benzoic acid effectively inhibits MCF-7 cell proliferation, migration, and clonogenicity, highlighting its potential as a promising therapeutic agent against breast cancer. Future studies are warranted to elucidate the underlying molecular mechanisms of BA’s anticancer effects and to evaluate its efficacy in in vivo models.
- 22 December 2025
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 50 (4) , 1114-1122
Open AccessBenzoic acid exerts antiproliferative, anti-migratory, and anti-clonogenic effects on MCF-7 breast cancer cells
Purpose: This study aims to investigate and emphasize the anticancer potential of benzoic acid in breast cancer cells. Materials and Methods: MCF-7 breast cancer cells were treated with benzoic acid at concentrations ranging from 0 to 1000 µM and incubated for 24 hours. Following treatment, both the effective and cytotoxic doses of benzoic acid were determined. Using these defined concentrations, comprehensive analyses were conducted to evaluate cell viability, cell migration (wound scratch assay), and clonogenic potential (colony formation assay), in order to elucidate the anticancer effects of benzoic acid. Results: Benzoic acid BA inhibited MCF-7 cell viability, migration, and colony formation in a dose-dependent manner. Cell viability was significantly reduced at concentrations ≥31.25 µM, with an IC₅₀ of ~166 µM, and dropped below 20% at 1000 µM. BA suppressed cell migration starting at 15 µM, reaching maximal inhibition at 1000 µM. Colony formation was also markedly impaired, with higher concentrations (250–1000 µM) nearly abolishing clonogenic potential. Conclusion: Benzoic acid effectively inhibits MCF-7 cell proliferation, migration, and clonogenicity, highlighting its potential as a promising therapeutic agent against breast cancer. Future studies are warranted to elucidate the underlying molecular mechanisms of BA’s anticancer effects and to evaluate its efficacy in in vivo models.